CAPITALSTARS PRESENTS EQUITY MARKET UPDATE : 22 JAN 2020

INDIAN FACE  

                      

INDIAN EQUITY BENCHMARK

The S&P BSE Sensex ended a volatile trading session at 41,115.38 level, down 208.43 points or 0.50 per cent on the back of cuts in blue chip companies like HDFC twins, ICICI Bank, Maruti Suzuk, and Kotak Mahindra Bank. At close, ONGC, NTPC, and Maruti Suzuki, down between 2 and 5 per cent, were the top drags on the Sensex, while Nestle India, TCS, and Infosys were the top gainers. Sensex hit a low of 41,301.63. 

GLOBAL FACE

Asian Market- Asian Markets Mixed as Investors Contemplate Coronavirus Threat. Asian stocks and currencies are mixed as investors grapple with the extent of the coronavirus outbreak and its potential implications on the global economy.

U.S. Market – The US equity market finished session lower for the first time in six consecutive sessions on Tuesday, 21 January 2020.Dow Jones Industrial Average shed 152.06 points, or 0.52%, to 29,196.04, ending its five-day streak of gains. The S&P 500 index fell 8.83 points, or 0.27%, to 3,320.79 and the Nasdaq Composite index was down 18.14 points, or 0.19%.

European markets- European markets muted as investors track coronavirus and earnings; DAX touches record high.

NIFTY SPOT

MARKET TALKS

Alembic Pharma's net profit surges 38% yoy in Q3FY20
Alembic Pharmaceuticals Limited reported its consolidated financial results for the quarter ending December 31, 2019. The pharma company's revenue for the quarter was up 19% yoy at Rs1,209cr from Rs1,018cr. Net Profit for the quarter up 38% yoy to Rs234cr from Rs170cr. International formulations grew 48% yoy to Rs664cr in the quarter. US Generics grew 61% yoy to Rs515cr in the quarter. Ex-US Sales grew 15% yoy to Rs149cr in the quarter. 8 ANDA approvals were received during the quarter and the total tally stand at 110. 6 ANDA filings were made during the quarter with cumulative ANDA filings standing at 176. 

Asian Paints' PAT rises 20% at Rs780cr in Q3FY20 
Asian Paints Ltd registered higher net profit at Rs764cr, up by 20% yoy in the third quarter ended December 31, 2019 as against Rs636cr during the quarter ended December31,2018. The company revenue rose 3% to Rs5,420cr in Q3FY20 vs.Rs5,263cr,Q3FY19. EBITDA for Q3FY20 came in at Rs1,189.4cr vs. Rs1,104.4cr in Q3FY19, up 7.7% yoy. Margins stood ar 21.9% vs. 21% in the corresponding quarter previous year, higher by 90bps yoy.

IndiaMART InterMESH reports PAT of Rs62cr yoy 
IndiaMART InterMESH on Tuesday reported a consolidated net profit for the quarter was at Rs62cr post deferred tax credit of Rs22.90cr in Q3FY20. Total revenue from operations came in at Rs165cr, 23% growth yoy, primarily due to an increase in the number of paying subscribers as well as a higher realization from existing customers. 

Havells India slips after muted Q3FY20 results
Shares of Havells India slipped.2.6% .The Company posted a 2.8% growth in net profit to Rs201cr in the quarter ended December 2019, as against Rs195.7cr in the corresponding quarter last year. Net sales of the company fell by 10% yoy to Rs2,273cr in Q3FY20 vs. Q3FY19. Anil Rai Gupta, Chairman and Managing Director, said that the slowdown in industrial products impacted the company's sales while the consumer segment remained stable.

NAME OF THE STOCK : GNFC

DATE : 22/1/2020

SEGMENT : CASH  

CHART TYPE : Candlestick

EXCHANGE : NSE 

TECHNICAL INDICATORS USED : VOLUME.MACD, RSI.

INVESTMENT ADVICE: CS CALL: - - BUY GNFC IN CASH NR CMP 202-203 TGT 212 SL 195.50.

RATIONALE FOR ARRIVING INVESTMENT ADVICE : We Provide Trading calls on the basis of following key points: 
1. Technical Analysis (Use of Candlestick Charts, Technical Indicators like: RSI, MACD, Stochastic, ADX etc,) 
2. Fundamentals of the Company 
3. Live Market News & Updates (Company related, Sector related, Economy related, political, Global news etc.) 
4. Tracking of Market Data’s (GDP, IIP, CPI, WPI, TRADE BALANCE etc.) 
5. Tracking of Market Events like (RBI POLICY, FED POLICY, ECB MEETING, and OPEC MEETING etc.) 
6. Tracking of Market Trends like Bullish Trend, Bearish Trend, and Consolidation etc.

DISCLAIMER

The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and upon sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as the only factor while making investment decisions. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets is always subjected to market risk.

CLICK HERE FOR GETTING DETAILS & JOIN OUR BEST ADVISORY  -

Visit our Link : https://www.capitalstars.com/free-trial

Visit My Website: https://www.capitalstars.com/

CAPITALSTARS CALL US : 9977499927

Derivatives Tips , Intraday Stock Tips , FreeTrading Tips, Sebi Registered advisory